SGMO - MorphoSys AG appoints Sangamo 's Sung Lee as new CFO

MorphoSys AG (MOR) names Sung Lee, coming from Sangamo Therapeutics (SGMO) and Gilead Sciences (GILD), as the company's new chief financial officer, effective Feb. 2, 2021.Lee succeeds Jens Holstein, who stepped down in Dec. 2020, and will lead all corporate finance functions in the U.S. and Europe. Prior to joining MorphoSys, Lee served as CFO at Sangamo Therapeutics and prior to that has spent nearly 14 years at Gilead Sciences where he most recently led the global financial planning & analysis and investor relations functions.Source: Press Release

For further details see:

MorphoSys AG appoints Sangamo 's Sung Lee as new CFO